Coherus Oncology (CHRS) Net Margin Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | 10,938.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,938.00 |
| Dec 31, 2025 | 12,780.00 |
| Sep 30, 2025 | -53,120.00 |
| Jun 30, 2025 | 293,417.00 |
| Mar 31, 2025 | -752,584.00 |
| Dec 31, 2024 | 2,751.00 |
| Sep 30, 2024 | 66,202.00 |
| Jun 30, 2024 | 48,026.00 |
| Mar 31, 2024 | 763,863.00 |
| Dec 31, 2023 | 4,278.00 |
| Sep 30, 2023 | 13,760.00 |
| Jun 30, 2023 | 1,036.00 |
| Mar 31, 2023 | -7,364.00 |
| Dec 31, 2022 | -6,753.00 |
| Sep 30, 2022 | -14,406.00 |
| Jun 30, 2022 | -4,926.00 |
| Mar 31, 2022 | 4,845.00 |
| Dec 31, 2021 | -7,107.00 |
| Sep 30, 2021 | -7,233.00 |
| Jun 30, 2021 | -8,017.00 |